Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 223-032-9 | CAS number: 3699-54-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
A LD50 value of >5000 mg/kg bw was observed for rats after acute oral and dermal exposure. There are no data available concerning acute inhalation toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Value:
- mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Value:
- mg/kg bw
Additional information
In two acute oral toxicity studies performed according to a protocol comparable to OECD guideline 401, 1-(2-hydroxyethyl) imidazolidin-2-one was tested in Wistar rats, 5 males and 5 females, by single oral gavage of 2000 mg/kg bw after which the animals were observed for 14 days (BASF AG, May 1988 and June 1988). In both studies no mortalities, body weight effects or clinical signs of toxicity were observed. Necropsy revealed no gross changes. The acute oral LD50 for 1-(2-hydroxyethyl) imidazolidin-2-one in male and female rats was greater than 2000 mg/kg bw.
In another study, the acute oral toxicity of 1-(2-hydroxyethyl) imidazolidin-2-one was assessed in Crl:CD® BR rats in a GLP compliant OECD guideline 401 study (Rohm and Haas, 2002). The test substance was identified as a clear liquid containing 75% active ingredient in water. Five male and five female rats were gavaged once with the undiluted test substance at 5000 mg/kg bw after which the animals were observed for 14 days. There were no mortalities, body weight effects, or clinical signs of toxicity. Necropsy revealed no gross changes. The acute oral LD50 for the substance in male and female rats was greater than 5000 mg/kg bw.
In a fourth study, the substance was also administered once by oral gavage to five rats of each sex at 2000 mg/kg bw in a GLP compliant OECD guideline 401 study (Akzo Nobel/NOTOX, 1995). The animals were observed for 14 days.
No mortality occurred. Hunched pasture and/or piloerection were observed in one male and one female on day 1. Body weight gain shown by the animals over the study period was considered to be normal. No abnormalities were found in the animals at macroscopic post mortem examination. The oral LD50 value of 1-(2-hydroxyethyl) imidazolidin-2-one in rats was established as exceeding 2000 mg/kg bw.
The acute dermal toxicity of the substance was assessed in Crl:CD®BR rats in a GLP compliant OECD guideline 402 study (Rohm and Haas, 2002).The test substance was identified as a clear liquid containing 75% active ingredient in water.The test substance was applied to the shaved intact skin of five male and five female rats at 5000 mg/kg bw. The application sites were occluded for 24 hours. After the 24 hour exposure, the application sites were wiped with paper towels saturated with tap water and blotted dry with paper towels. The animals were observed for 14 days.
There were no mortalities, clinical signs of systemic toxicity, or body weight effects.
No skin irritation effects were observed. Necropsy revealed no gross changes. The acute dermal LD50 for the substance was greater than 5000 mg/kg bw in male and female rats.
Justification for classification or non-classification
Based on the results of the acute oral and dermal toxicity studies, 1-(2-hydroxyethyl) imidazolidin-2-one needs not to be classified according to Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.